Definitive chemoradiotherapy is the standard of care for inoperable locoregionally advanced
esophageal squamous cell carcinoma (ESCC). Immune checkpoint inhibitors such as anti-…

Importance The role of postoperative radiotherapy (PORT) has not been well defined in resected
pIIIA-N2 non–small cell lung cancer (NSCLC). Objective To evaluate the effect of PORT …

Background Effective tools evaluating the prognosis for patients with esophageal cancer
undergoing surgery is lacking. The current study aimed to develop a nomogram to predict …

BACKGROUND: Whether the combination of high dose-rate brachytherapy (HDRBT) and
External Beam Radiation Therapy (EBRT) is superior to HDRBT alone for the palliation of …

Background Our previous study indicated the survival rate for esophageal squamous cell
cancer (ESCC) patients in stage III and positive lymph node groups with postoperative …

Introduction Primary small cell esophageal carcinoma (SCEC) is a rare and aggressive
disease for which there is no recommended standard treatment at this time. Methods A total of …

Cancer cells associated with radioresistance are likely to give rise to local recurrence and
distant metastatic relapse. However, it remains unclear whether specific miRNAs have direct …

Background The role of postoperative radiotherapy in pathological T2–3N0M0 esophageal
squamous cell carcinoma is unknown. We aimed to evaluate the efficacy and safety of …

Learning Objectives After completing this course, the reader will be able to: Describe the
present clinical practice and controversies regarding the use of PORT in resected pIIIA‐pN2 …

Purpose We intended to identify risk factors that affect brain metastases (BM) in patients
with locally advanced non-small cell lung cancer (LA-NSCLC) receiving definitive radiation …